Polymer micelles as drug carriers

Nanoparticulates as Drug Carriers

Volumn , Issue , 2006, Pages 57-93

  Batrakova, Elena V ^a   Bronich, Tatiana K ^a   Vetro, Joseph A ^a   Kabanov, Alexander V ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; POLYMER MICELLES;

DRUG DELIVERY;

EID: 84967566793     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9781860949074_0005     Document Type: Chapter

References (199)

1. Ehrlich P (1956) The relationship existing between chemical constitution, distribution, and pharmacological action, in Himmelweite F, Marquardt M and Dale H (eds.) The Collected Papers of Paul Ehrlich. Pergamon, Elmsford, New York, Vol. 1, pp. 596-618.
2. Lipinski CA, Lombardo F, Dominy BW and Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Del Rev 46:3-26.
3. Fernandez AM, Van Derpoorten K, Dasnois L, Lebtahi K, Dubois V, Lobl TJ, Gangwar S, Oliyai C, Lewis ER, Shochat D and Trouet A (2001) N-Succinyl-(beta-alanyl-L-leucyl-L-alanyl-L-leucyl)doxorubicin: An extracellularly tumor-activated prodrug devoid of intravenous acute toxicity. J Med Chem 44:3750-3753.
4. Thompson TN (2001) Optimization of metabolic stability as a goal of modern drug design. Med Res Rev 21:412-449.
5. Langer R (2001) Drug delivery. Drugs on target. Science 293:58-59.
6. Duncan R (2003) The dawning era of polymer therapeutics. Nat Rev Drug Discov 2:347-360.
7. Kabanov AV and Kabanov VA (1995) DNA complexes with polycations for the delivery of genetic material into cells. Bioconjug Chem 6:7-20.
8. Kakizawa Y and Kataoka K (2002) Block copolymer micelles for delivery of gene and related compounds. Adv Drug Del Rev 54:203-222.
9. Kabanov AV and Alakhov VY (2002) Pluronic block copolymers in drug delivery: From micellar nanocontainers to biological response modifiers. Crit Rev Ther Drug Carr Syst 19:1-72.
10. Savic R, Luo L, Eisenberg A and Maysinger D (2003) Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 300:615-618.
11. Hubbell JA (2003) Materials science. Enhancing drug function. Science 300:595-596.
12. Salem AK, Searson PC and Leong KW (2003) Multifunctional nanorods for gene delivery. Nat Mater 2:668-671.
13. Kabanov AV, Nazarova IR, Astafieva IV, Batrakova EV, Alakhov VY, Yaroslavov AA and Kabanov VA (1995) Micelle formation and solubilization of fluorescent probes in poly(oxyethylene-b-oxypropylene-b-oxyethylene) solutions. Macromolecules 28: 2303-2314.
14. Allen C, Maysinger D and Eisenberg A (1999) Nano-engineering block copolymer aggregates for drug delivery. Coll Surf B: Biointerf 16:3-27.
15. Kataoka K, Harada A and Nagasaki Y (2001) Block copolymer micelles for drug delivery: Design, characterization and biological significance. Adv Drug Del Rev 47:113-131.
16. Adams ML, Lavasanifar A and Kwon GS (2003) Amphiphilic block copolymers for drug delivery. J Pharm Sci 92:1343-1355.
17. Sakuma S, Hayashi M and Akashi M (2001) Design of nanoparticles composed of graft copolymers for oral peptide delivery. Adv Drug Del Rev 47:21-37.
18. Francis MF, Lavoie L, Winnik FM and Leroux JC (2003) Solubilization of cyclosporin A in dextran-g-polyethyleneglycolalkyl ether polymeric micelles. Eur J Pharm Biopharm 56:337-346.
19. Francis MF, Piredda M and Winnik FM (2003) Solubilization of poorly water soluble drugs in micelles of hydrophobically modified hydroxypropylcellulose copolymers. J Control Rel 93:59-68.
20. Jeong B, Bae YH and Kim SW (2000) Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers. J Control Rel 63:155-163.
21. Yoo HS and Park TG (2001) Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer. J Control Rel 70:63-70.
22. Duncan R and Kopecek J (1984) Soluble synthetic polymers as potential drug carriers. Adv Polym Sci 57:51-101.
23. Torchilin VP (2004) Targeted polymeric micelles for delivery of poorly soluble drugs. Cell Mol Life Sci 61:2549-2559.
24. Torchilin VP (2001) Structure and design of polymeric surfactant-based drug delivery systems. J Control Rel 73:137-172.
25. Moghimi SM, Hunter AC and Murray JC (2001) Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol Rev 53:283-318.
26. Lukyanov AN, Gao Z and Torchilin VP (2003) Micelles from polyethylene gly-col/phosphatidylethanolamine conjugates for tumor drug delivery. J Control Rel 91:97-102.
27. Zhang L, Yu K and Eisenberg A (1996) Ion-Induced morphological changes in “crew-cut” aggregates of amphiphilic block copolymers. Science 272:1777-1779.
28. Kabanov AV and Alakhov VY (2000) Micelles of amphilphilic block copolymers as vehicles for drug delivery, in, Alexandridis P and Lindman B (eds.) Amphiphilic Block Copolymers: Self-Assembly and Applications: Elsevier: Amsterdam, Lausanne, New York, Oxford, Shannon, Singapore, Tokyo, pp. 347-376.
29. Kwon GS and Okano T (1999) Soluble self-assembled block copolymers for drug delivery. Pharm Res 16:597-600.
30. Kim KH, Guo HC, Lim HJ, Huh J, Ahn C-H and Jo WH (2004) Synthesis and micelliza-tion of star-shaped poly (ethylene glycol)-block-poly(e-caprolactone). Macromolec Chem Phys 205:1684-1692.
31. Gitsov I and Frechet JMJ (1993) Solution and solid-state properties of hybrid linear-dendritic block copolymers. Macromolecules 26:6536-6546.
32. Gitsov I, Lambrych KR, Remnant VA and Pracitto R (2000) Micelles with highly branched nanoporous interior: Solution properties and binding capabilities of amphiphilic copolymers with linear dendritic architecture. J Polym Sci Part A: Polym Chem 38:2711-2727.
33. Hawker CJ, Wooley KL and Frechet JMJ (1993) Unimolecular micelles and globular amphiphiles: Dendritic macromolecules as novel recyclable solubilization agents. J Chem Soc Perkin Trans 1: Org Bio-Org Chem (1972-1999):1287-1297.
34. Tomalia DA, Berry V, Hall M and Hedstrand DM (1987) Starburst dendrimers. 4. Covalently fixed unimolecular assemblages reiminiscent of spheroidal micelles. Macromolecules 20:1164-1167.
35. Stevelmans S, Hest JCMv, Jansen JFGA, Van Boxtel DAFJ, de Berg EMM and Meijer EW (1996) Synthesis, characterization, and guest-host properties of inverted unimolecular dendritic micelles. J Am Chem Soc 118:7398-7399.
36. van Hest JCM, Delnoye DAP, Baars MWPL, van Genderen MHP and Meijer EW (1995) Polystyrene-dendrimer amphiphilic block copolymers with a generation-dependent aggregation. Science 268:1592-1595.
37. van Hest JCM, Elissen-Roman C, Baars MWPL, Delnoye DAP, Van Genderen MHP and Meijer EW (1995) Polystyrene-poly(propylene imine) dendrimer block copolymers: A new class of amphiphiles. Polym Mater Sci Eng 73:281-282.
38. Lorenz K, Muelhaupt R, Frey H, Rapp U and Mayer-Posner FJ (1995) Carbosilane-Based Dendritic Polyols. Macromolecules 28:6657-6661.
39. Gitsov I and Frechet JMJ (1996) Stimuli-responsive hybrid macromolecules: novel amphiphilic star copolymers with dendritic groups at the periphery. J Am Chem Soc 118:3785-3786.
40. Liu M, Kono K and Frechet JM (2000) Water-soluble dendritic unimolecular micelles: Their potential as drug delivery agents. J Control Rel 65:121-131.
41. Kojima C, Kono K, Maruyama K and Takagishi T (2000) Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconjug Chem 11:910-917.
42. Wang F, Bronich TK, Kabanov AV, Rauh RD and Roovers J (2005) Synthesis and evaluation of a star amphiphilic block copolymer from poly(epsilon-caprolactone) and poly(ethylene glycol) as a potential drug delivery carrier. Bioconjug Chem 16:397-405.
43. Heise A, Hedrick JL, Frank CW and Miller RD (1999) Starlike block copolymers with amphiphilic arms as models for unimolecular micelles. J Am Chem Soc 121:8647-8648.
44. Liu H, Jiang A, Guo J and Uhrich KE (1999) Unimolecular micelles: synthesis and characterization of amphiphilic polymer systems. J Polym Sci Part A: Polym Chem 37: 703-711.
45. Antoun S, Gohy JF and Jerome R (2001) Micellization of quaternized poly(2-(dimethylamino)ethyl methacrylate)-block-poly(methyl methacrylate) copolymers in water. Polym 42:3641-3648.
46. Jones M-C, Ranger M and Leroux J-C (2003) pH-sensitive unimolecular polymeric micelles: Synthesis a novel drug carrier. Bioconjug Chem 14:774-781.
47. Morton M, Helminiak TE, Gadkary SD and Bueche J (1962) Preparation and properties of monodisperse branched polystyrene. J Polym Sci 57:471-482.
48. Gauthier M, Li J and Dockendorff J (2003) Arborescent polystyrene-graft-poly(2-vinylpyridine) copolymers as unimolecular micelles. Synthesis from acetylated substrates. Macromolecules 36:2642-2648.
49. Iijima M, Nagasaki Y, Okada T, Kato M and Kataoka K (1999) Core-polymerized reactive micelles from heterotelechelic amphiphilic block copolymers. Macromolecules 32:1140-1146.
50. Kim J-H, Emoto K, Iijima M, Nagasaki Y, Aoyagi T, Okano T, Sakurai Y and Kataoka K (1999) Core-stabilized polymeric micelle as potential drug carrier: increased solubilization of taxol. Polym Adv Technol 10:647-654.
51. Guo A, Liu G and Tao J (1996) Star polymers and nanospheres from cross-linkable diblock copolymers. Macromolecules 29:2487-2493.
52. Won Y-Y, Davis HT and Bates FS (1999) Giant wormlike rubber micelles. Science 283:960-963.
53. Rapoport N (1999) Stabilization and activation of Pluronic micelles for tumor-targeted drug delivery. Coll Surf B: Biointerf 16:93-111.
54. Thurmond KB, II, Huang H, Clark CG, Jr., Kowalewski T and Wooley KL (1999) Shell crosslinked polymer micelles: Stabilized assemblies with great versatility and potential. Coll Surf B: Biointerf 16:45-54.
55. Zhang Q, Remsen EE and Wooley KL (2000) Shell cross-linked nanoparticles containing hydrolytically degradable, crystalline core domains. J Am Chem Soc 122: 3642-3651.
56. Buetuen V, Lowe AB, Billingham NC and Armes SP (1999) Synthesis of zwitterionic shell cross-linked micelles. J Am Chem Soc 121:4288-4289.
57. Bronich TK and Kabanov AV (2004) Novel block ionomer micelles with cross-linked ionic cores. Polym Prepr 45:384-385.
58. Bader H, Ringsdorf H and Schmidt B (1984) Water-soluble polymers in medicine. Angew Makromol Chem 123/124:457-485.
59. Duncan R (2003) The dawning era of polymer therapeutics. Nat Rev Drug Discov 2:347-360.
60. Bulmus V, Woodward M, Lin L, Murthy N, Stayton P and Hoffman A (2003) A new pH-responsive and glutathione-reactive, endosomal membrane-disruptive polymeric carrier for intracellular delivery of biomolecular drugs. J Control Rel 93: 105-120.
61. Veronese FM and Morpurgo M (1999) Bioconjugation in pharmaceutical chemistry. Farmaco 54:497-516.
62. D’Souza AJ and Topp EM (2004) Release from polymeric prodrugs: Linkages and their degradation. J Pharm Sci 93:1962-1979.
63. Bae Y, Fukushima S, Harada A and Kataoka K (2003) Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: Polymeric micelles that are responsive to intracellular pH change. Angewandte Chemie, Int Edn 42:4640-4643, S4640/1-S4640/11.
64. Bae Y, Nishiyama N, Fukushima S, Koyama H, Yasuhiro M and Kataoka K (2005) Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: Tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjug Chem 16:122-130.
65. Yokoyama M (1992) Block copolymers as drug carriers. Crit Rev Ther Drug Carr Syst 9:213-248.
66. Yokoyama M, Sugiyama T, Okano T, Sakurai Y, Naito M and Kataoka K (1993) Analysis of micelle formation of an adriamycin-conjugated polyethylene glycol-poly(aspartic acid) block copolymer by gel permeation chromatography. Pharm Res 10:895-899.
67. Yokoyama M, Fukushima S, Uehara R, Okamoto K, Kataoka K, Sakurai Y and Okano T (1998) Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor. J Control Rel 50:79-92.
68. Kabanov AV, Chekhonin VP, Alakhov VY, Batrakova EV, Lebedev AS, Melik-Nubarov NS, Arzhakov SA, Levashov AV, Morozov GV, Severin ES and Kabanov VA (1989) The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting. FEBS Lett 258:343-345.
69. La SB, Okano T and Kataoka K (1996) Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(beta-benzyl L-aspartate) block copolymer micelles. J Pharm Sci 85:85-90.
70. Yokoyama M, Satoh A, Sakurai Y, Okano T, Matsumura Y, Kakizoe T and Kataoka K (1998) Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. J Control Rel 55:219-229.
71. Inoue T, Chen G, Nakamae K and Hoffman AS (1998) An AB block copolymer of oligo(methyl methacrylate) and poly(acrylic acid) for micellar delivery of hydrophobic drugs. J Control Rel 51:221-229.
72. Allen C, Han J, Yu Y, Maysinger D and Eisenberg A (2000) Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone. J Control Rel 63:275-286.
73. Kabanov AV, Batrakova EV, Melik-Nubarov NS, Fedoseev NA, Dorodnich TY, Alakhov VY, Chekhonin VP, Nazarova IR and Kabanov VA (1992) A new class of drug carriers: Micelles of poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainers for drug targeting from blood in brain. J Control Rel 22:141-157.
74. Burt HM, Zhang X, Toleikis P, Embree L and Hunter WL (1999) Development of copolymers of poly(DL-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel. Coll Surf, B: Biointerf 16:161-171.
75. Lavasanifar A, Samuel J and Kwon GS (2001) Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate L-aspartamide) by a solvent evaporation method: Effect on the solubilization and haemolytic activity of amphotericin B. J Control Rel 77:155-160.
76. Lavasanifar A, Samuel J, Sattari S and Kwon GS (2002) Block copolymer micelles for the encapsulation and delivery of amphotericin B. Pharm Res 19:418-422.
77. Hurter PN, Scheutjens JMHM and Hatton TA (1993) Molecular modeling of micelle formation and solubilization in block copolymer micelles. 1. A self-consistent meanfield lattice theory. Macromolecules 26:5592-5601.
78. Nagarajan R and Ganesh K (1996) Comparison of solubilization of hydrocarbons in (PEO-PPO) diblock versus (PEO-PPO-PEO) triblock copolymer micelles. J Coll Interf Sci 184:489-499.
79. Xing L and Mattice WL (1997) Strong solubilization of small molecules by triblockcopolymer micelles in selective solvents. Macromolecules 30:1711-1717.
80. Gadelle F, Koros WJ and Schechter RS (1995) Solubilization of aromatic solutes in block copolymers. Macromolecules 28:4883-4892.
81. Nagarajan R, Barry M and Ruckenstein E (1986) Unusual selectivity in solubilization by block copolymer micelles. Langmuir 2:210-215.
82. Liu J, Xiao Y and Allen C (2004) Polymer-drug compatibility: A guide to the development of delivery systems for the anticancer agent, ellipticine. J Pharm Sci 93:132-143.
83. Nagarajan R and Ganesh K (1989) Block copolymer self-assembly in selective solvents: Theory of solubilization in spherical micelles. Macromolecules 22:4312-4325.
84. Hurter PN and Hatton TA (1992) Solubilization of polycyclic aromatic hydrocarbons by poly(ethylene oxide-propylene oxide) block copolymer micelles: Effects of polymer structure. Langmuir 8:1291-1299.
85. Kozlov MY, Melik-Nubarov NS, Batrakova EV and Kabanov AV (2000) Relationship between pluronic block copolymer structure, critical micellization concentration and partitioning coefficients of low molecular mass solutes. Macromolecules 33: 3305-3313.
86. Hurter PN, Scheutjens JMHM and Hatton TA (1993) Molecular modeling of micelle formation and solubilization in block copolymer micelles. 2. Lattice theory for monomers with internal degrees of freedom. Macromolecules 26:5030-5040.
87. Teng Y, Morrison ME, Munk P, Webber SE and Prochazka K (1998) Release kinetics studies of aromatic molecules into water from block polymer micelles. Macromolecules 31:3578-3587.
88. Choucair A and Eisenberg A (2003) Interfacial solubilization of model amphiphilic molecules in block copolymer micelles. J Am Chem Soc 125:11993-12000.
89. Kim SY, Shin IG, Lee YM, Cho CS and Sung YK (1998) Methoxy poly(ethylene glycol) and epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. II. Micelle formation and drug release behaviours. J Control Rel 51:13-22.
90. Kabanov AV, Vinogradov SV, Suzdaltseva YG and Alakhov VY (1995) Water-soluble block polycations as carriers for oligonucleotide delivery. Bioconjug Chem 6:639-643.
91. Harada A and Kataoka K (1995) Formation of polyion complex micelles in an aqueous milieu from a pair of oppositely-charged block copolymers with poly(ethylene glycol) segments. Macromolecules 28:5294-5299.
92. Kabanov VA and Kabanov AV (1998) Interpolyelectrolyte and block ionomer complexes for gene delivery: Physico-chemical aspects. Adv Drug Del Rev 30:49-60.
93. Solomatin SV, Bronich TK, Kabanov VA, Eisenberg A and Kabanov AV (2001) Block ionomer complexes: Novel environmentally responsive materials. Polym Prepr 42: 107-108.
94. Solomatin SV, Bronich TK, Eisenberg A, Kabanov VA and Kabanov AV (2003) Environmentally responsive nanoparticles from block ionomer complexes: Effects of pH and ionic strength. Langmuir 19:8069-8076.
95. Zhang G-D, Harada A, Nishiyama N, Jiang D-L, Koyama H, Aida T and Kataoka K (2003) Polyion complex micelles entrapping cationic dendrimer porphyrin: Effective photosensitizer for photodynamic therapy of cancer. J Control Rel 93:141-150.
96. Itaka K, Kanayama N, Nishiyama N, Jang W-D, Yamasaki Y, Nakamura K, Kawaguchi H and Kataoka K (2004) Supramolecular Nanocarrier of siRNA from PEG-Based Block Catiomer Carrying Diamine Side Chain with Distinctive pKa Directed To Enhance Intracellular Gene Silencing. J Am Chem Soc 126:13612-13613.
97. Kabanov AV and Bronich TK (2002) Structure, dispersion stability and dynamics of DNA and polycation complexes, in Kim SW and Mahato R (eds.) Pharmaceutical Perspectives of Nucleic Acid-Based Therapeutics. Taylor & Francis; London, New York, pp. 164-189.
98. Yokoyama M, Okano T, Sakurai Y, Suwa S and Kataoka K (1996) Introduction of cisplatin into polymeric micelle. J Control Rel 39:351-356.
99. Nishiyama N, Yokoyama M, Aoyagi T, Okano T, Sakurai Y and Kataoka K (1999) Preparation and characterization of self-assembled polymer-metal complex micelle from cis-dichlorodiammineplatinum(II) and poly(ethylene glycol)-poly(alpha.,.beta.-aspartic acid) block copolymer in an aqueous medium. Langmuir 15:377-383.
100. Holleb AI, Fink DJ and Murphy GP (eds.) (1991) American Cancer Society Textbook of Clinical Oncology. American Cancer Society: Atlanta, GA.
101. Sherman SE and Lippard SJ (1987) Structural aspects of platinum anticancer drug interactions with DNA. Chem Rev 87:1153-1181.
102. Nishiyama N and Kataoka K (2001) Preparation and characterization of size-controlled polymeric micelle containing cis-dichlorodiammineplatinum(II) in the core. J Control Rel 74:83-94.
103. Nishiyama N, Okazaki S, Cabral H, Miyamoto M, Kato Y, Sugiyama Y, Nishio K, Matsumura Y and Kataoka K (2003) Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res 63:8977-8983.
104. Jang W-D, Nishiyama N, Zhang G-D, Harada A, Jiang D-L, Kawauchi S, Morimoto Y, Kikuchi M, Koyama H, Aida T and Kataoka K (2005) Supramolecular nanocarrier of anionic dendrimer porphyrins with cationic block copolymers modified with polyethylene glycol to enhance intracellular photodynamic efficacy. Angewandte Chemie, Int Edn 44:419-423.
105. Stapert HR, Nishiyama N, Jiang D-L, Aida T and Kataoka K (2000) Polyion complex micelles encapsulating light-harvesting ionic dendrimer zinc porphyrins. Langmuir 16:8182-8188.
106. Harada A and Kataoka K (1998) Novel polyion complex micelles entrapping enzyme molecules in the core: Preparation of narrowly-distributed micelles from lysozyme and poly(ethylene glycol)-poly(aspartic acid) block copolymer in aqueous medium. Macromolecules 31:288-294.
107. Kawamura A, Yoshioka Y, Harada A and Kono K (2005) Acceleration of enzymatic reaction of trypsin through the formation of water-soluble complexes with poly(ethylene glycol)-block-poly(a,b-aspartic acid). Biomacromolecules 6:627-631.
108. Harada A and Kataoka K (2003) Switching by pulse electric field of the elevated enzymatic reaction in the core of polyion complex micelles. J Am Chem Soc 125:15306-15307.
109. Bronich TK, Kabanov AV, Kabanov VA, Yu K and Eisenberg A (1997) Soluble complexes from poly(ethylene oxide)-block-polymethacrylate anions and N-alkylpyridinium cations. Macromolecules 30:3519-3525.
110. Bronich TK, Cherry T, Vinogradov SV, Eisenberg A, Kabanov VA and Kabanov AV (1998) Self-assmbly in mixtures of poly(ethylene oxide)-graft-poly(ethyleneimine) and alkyl sulfates. Langmuir 14:6101-6106.
111. Kabanov AV, Bronich TK, Kabanov VA, Yu K and Eisenberg A (1998) Spontaneous formation of vesicles from complexes of block ionomers and surfactants. J Am Chem Soc 120:9941-9942.
112. Bronich TK, Popov AM, Eisenberg A, Kabanov VA and Kabanov AV (2000) Effects of block length and structure of surfactant on self-assembly and solution behavior of block ionomer complexes. Langmuir 16:481-489.
113. Bronich TK, Ouyang M, Kabanov VA, Eisenberg A, Szoka FC, Jr. and Kabanov AV (2002) Synthesis of vesicles on polymer template. J Am Chem Soc 124:11872-11873.
114. Bronich TK, Nehls A, Eisenberg A, Kabanov VA and Kabanov AV (1999) Novel drug delivery systems based on the complexes of block ionomers and surfactants of opposite charge. Col Surf B 16:243-251.
115. Solomatin SV, Bronich TK, Eisenberg A, Kabanov VA and Kabanov AV (2004) Colloidal stability of aqueous dispersions of block ionomer complexes: Effects of temperature and salt. Langmuir 20: 2066-2068.
116. Pinzani V, Bressolle F, Haug IJ, Galtier M, Blayac JP and Balmes P (1994) Cisplatin-induced renal toxicity and toxicity-modulating strategies: A review. Cancer Chemother Pharmacol 35:1-9.
117. Weinstein DM, Mihm MJ and Bauer JA (2000) Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice. J Pharmacol Exp Ther 294:396-401.
118. Kwon GS and Kataoka K (1995) Block copolymer micelles as long-circulating drug vehicles. Adv Drug Del Rev 16:295-309.
119. Batrakova EV, Li S, Li Y, Alakhov VY, Elmquist WF and Kabanov AV (2004) Distribution kinetics of a micelle-forming block copolymer Pluronic P85. J Control Rel 100:389-397.
120. Fraser JR, Laurent TC, Pertoft H and Baxter E (1981) Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. Biochem J 200:415-424.
121. Kissel M, Peschke P, Subr V, Ulbrich K, Schuhmacher J, Debus J and Friedrich E (2001) Synthetic macromolecular drug carriers: Biodistribution of poly[(N-2-hydroxypropyl)methacrylamide] copolymers and their accumulation in solid rat tumors. PDA J Pharm Sci Technol 55:191-201.
122. Matsumura Y and Maeda H (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46:6387-6392.
123. Maeda H (2001) The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 41:189-207.
124. Giblin MF, Veerendra B and Smith CJ (2005) Radiometallation of receptor-specific peptides for diagnosis and treatment of human cancer. In Vivo 19:9-29.
125. Rini BI (2005) VEGF-targeted therapy in metastatic renal cell carcinoma. Oncologist 10:191-197.
126. Lin MZ, Teitell MA and Schiller GJ (2005) The evolution of antibodies into versatile tumor-targeting agents. Clin Cancer Res 11:129-138.
127. Levi FA, Hrashesky WJ, Halberg F, Langevin TR, Haus E and Kennedy BJ (1982) Lethal nephrotoxicity and hematologic toxicity of cis-diamminedichloroplatinum ameliorated by optimal circadian timing and hydration. Eur J Cancer Clin Oncol 18:471-477.
128. Greish K, Sawa T, Fang J, Akaike T and Maeda H (2004) SMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours. J Control Rel 97: 219-230.
129. Lee ES, Na K and Bae YH (2005) Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J Control Rel 103:405-418.
130. Alakhov V, Klinski E, Li S, Pietrzynski G, Venne A, Batrakova E, Bronitch T and Kabanov AV (1999) Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials. Coll Surf B: Biointerf 16:113-134.
131. Kim SC, Kim DW, Shim YH, Bang JS, Oh HS, Wan Kim S and Seo MH (2001) In vivo evaluation of polymeric micellar paclitaxel formulation: Toxicity and efficacy. J Control Rel 72:191-202.
132. Torchilin VP, Lukyanov AN, Gao Z and Papahadjopoulos-Sternberg B (2003) Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs. Proc Natl Acad Sci USA 100:6039-6044.
133. Taillefer J, Brasseur N, van Lier JE, Lenaerts V, Le Garrec D and Leroux JC (2001) In vitro and in vivo evaluation of pH-responsive polymeric micelles in a photodynamic cancer therapy model. J Pharm Pharmacol 53:155-166.
134. Le Garrec D, Taillefer J, Van Lier JE, Lenaerts V and Leroux JC (2002) Optimizing pH-responsive polymeric micelles for drug delivery in a cancer photodynamic therapy model. J Drug Targ 10:429-437.
135. Yokoyama M, Okano T, Sakurai Y, Fukushima S, Okamoto K and Kataoka K (1999) Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system. J Drug Targ 7:171-186.
136. Greish K, Nagamitsu A, Fang J and Maeda H (2005) Copoly(styrene-maleic acid)-pirarubicin micelles: High tumor-targeting efficiency with little toxicity. Bioconjug Chem 16:230-236.
137. Nasongkla N, Shuai X, Ai H, Weinberg BD, Pink J, Boothman DA and Gao J (2004) cRGD-functionalized polymer micelles for targeted doxorubicin delivery. Angew Chem Int Ed Engl 43:6323-6327.
138. Paulos CM, Turk MJ, Breur GJ and Low PS (2004) Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Adv Drug Del Rev 56:1205-1217.
139. Yoo HS and Park TG (2004) Folate receptor targeted biodegradable polymeric doxorubicin micelles. J Control Rel 96:273-283.
140. Allen TM (2002) Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2:750-763.
141. Gao Z, Lukyanov AN, Chakilam AR and Torchilin VP (2003) PEG-PE/phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing. J Drug Targ 11:87-92.
142. Tannock IF and Rotin D (1989) Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 49:4373-4384.
143. Kataoka K, Matsumoto T, Yokoyama M, Okano T, Sakurai Y, Fukushima S, Okamoto K and Kwon GS (2000) Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: Their pharmaceutical characteristics and biological significance. J Control Rel 64:143-153.
144. Yoo HS, Lee EA and Park TG (2002) Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages. J Control Rel 82:17-27.
145. Hruby M, Konak C and Ulbrich K (2005) Polymeric micellar pH-sensitive drug delivery system for doxorubicin. J Control Rel 103:137-148.
146. Kabanov AV, Bronich TK, Kabanov VA, Yu K and Eisenberg A (1996) Soluble stoichiometric complexes from poly(N-ethyl-4-vinylpyridinium) cations and poly(ethylene oxide)-block-polymethacrylate anions. Macromolecules 29:6797-6802.
147. Lee ES, Shin HJ, Na K and Bae YH (2003) Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization. J Control Rel 90:363-374.
148. Alakhov VY, Moskaleva EY, Batrakova EV and Kabanov AV (1996) Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer. Bioconjug Chem 7:209-216.
149. Venne A, Li S, Mandeville R, Kabanov A and Alakhov V (1996) Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells. Cancer Res 56:3626-3629.
150. Batrakova EV, Dorodnych TY, Klinskii EY, Kliushnenkova EN, Shemchukova OB, Goncharova ON, Arjakov SA, Alakhov VY and Kabanov AV (1996) Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: In vivo evaluation of anti cancer activity. Br J Cancer 74:1545-1552.
151. Kabanov AV, Batrakova EV and Alakhov VY (2002) Pluronic block copolymers for overcoming drug resistance in cancer. Adv Drug Deliv Rev 54:759-779.
152. Batrakova EV, Lee S, Li S, Venne A, Alakhov V and Kabanov A (1999) Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells. Pharm Res 16:1373-1379.
153. Miller DW, Batrakova EV and Kabanov AV (1999) Inhibition of multidrug resistance-associated protein (MRP) functional activity with pluronic block copolymers. Pharm Res 16:396-401.
154. Batrakova EV, Li S, Alakhov VY, Elmquist WF, Miller DW and Kabanov AV (2003) Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85. Pharm Res 20:1581-1590.
155. Minko T, Batrakova E, Li S, Li Y, Pakunlu R, Alakhov V and Kabanov A (2005) Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells. J Control Rel.
156. Batrakova EV, Han HY, Miller DW and Kabanov AV (1998) Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells. Pharm Res 15:1525-1532.
157. Evers R, Kool M, Smith AJ, van Deemter L, de Haas M and Borst P (2000) Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1-and MRP2-mediated transport. Br J Cancer 83:366-374.
158. Batrakova EV, Miller DW, Li S, Alakhov VY, Kabanov AV and Elmquist WF (2001) Pluronic P85 enhances the delivery of digoxin to the brain: In vitro and in vivo studies. J Pharmacol Exp Ther 296:551-557.
159. Miller DW, Batrakova EV, Waltner TO, Alakhov V and Kabanov AV (1997) Interactions of pluronic block copolymers with brain microvessel endothelial cells: Evidence of two potential pathways for drug absorption. Bioconjug Chem 8:649-657.
160. Batrakova EV, Li S, Elmquist WF, Miller DW, Alakhov VY and Kabanov AV (2001) Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion. Br J Cancer 85:1987-1997.
161. Batrakova EV, Li S, Vinogradov SV, Alakhov VY, Miller DW and Kabanov AV (2001) Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: Contributions of energy depletion and membrane fluidization. J Pharmacol Exp Ther 299:483-493.
162. Batrakova EV, Li S, Alakhov VY, Miller DW and Kabanov AV (2003) Optimal structure requirements for Pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells. J Pharmacol Exp Ther 304:845-854.
163. Rapoport N, Marin AP and Timoshin AA (2000) Effect of a polymeric surfactant on electron transport in HL-60 cells. Arch Biochem Biophys 384:100-108.
164. Kabanov AV, Batrakova EV and Alakhov VY (2003) An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers. J Control Rel 91:75-83.
165. Batrakova EV, Li S, Miller DW and Kabanov AV (1999) Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers. Pharm Res 16:1366-1372.
166. Batrakova EV, Zhang Y, Li Y, Li S, Vinogradov SV, Persidsky Y, Alakhov V, Miller DW and Kabanov AV (2004) Effects of Pluronic P85 on GLUT1 and MCT1 transporters in the blood brain barrier. Pharm Res in press.
167. Kabanov AV, Batrakova EV and Miller DW (2003) Pluronic((R)) block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier. Adv Drug Del Rev 55:151-164.
168. Kabanov AV and Batrakova EV (2004) New technologies for drug delivery across the blood brain barrier. Curr Pharm Des 10:1355-1363.
169. Kwon GS (2003) Polymeric micelles for delivery of poorly water-soluble compounds. Crit Rev Ther Drug Carr Syst 20:357-403.
170. Adams ML and Kwon GS (2003) Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles: Effects of acyl chain length. J Control Rel 87:23-32.
171. Adams ML, Andes DR and Kwon GS (2003) Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity. Biomacromolecules 4:750-757.
172. Croy SR and Kwon GS (2004) The effects of Pluronic block copolymers on the aggregation state of nystatin. J Control Rel 95:161-171.
173. Jagannath C, Sepulveda E, Actor JK, Luxem F, Emanuele MR and Hunter RL (2000) Effect of poloxamer CRL-1072 on drug uptake and nitric-oxide-mediated killing of Mycobacterium avium by macrophages. Immunopharmacology 48: 185-197.
174. Jagannath C, Emanuele MR and Hunter RL (2000) Activity of poloxamer CRL-1072 against drug-sensitive and resistant strains of Mycobacterium tuberculosis in macrophages and in mice. Int J Antimicrob Agents 15:55-63.
175. Jagannath C, Emanuele MR and Hunter RL (1999) Activities of poloxamer CRL-1072 against Mycobacterium avium in macrophage culture and in mice. Antimicrob Agents Chemother 43:2898-2903.
176. Jagannath C, Wells A, Mshvildadze M, Olsen M, Sepulveda E, Emanuele M, Hunter RL, Jr. and Dasgupta A (1999) Significantly improved oral uptake of amikacin in FVB mice in the presence of CRL-1605 copolymer. Life Sci 64:1733-1738.
177. Torchilin VP (2002) PEG-based micelles as carriers of contrast agents for different imaging modalities. Adv Drug Del Rev 54:235-252.
178. Trubetskoy VS, Frank-Kamenetsky MD, Whiteman KR, Wolf GL and Torchilin VP (1996) Stable polymeric micelles: Lymphangiographic contrast media for gamma scintigraphy and magnetic resonance imaging. Acad Radiol 3:232-238.
179. Trubetskoy VS, Gazelle GS, Wolf GL and Torchilin VP (1997) Block-copolymer of polyethylene glycol and polylysine as a carrier of organic iodine: Design of long-circulating particulate contrast medium for X-ray computed tomography. J Drug Targ 4:381-388.
180. Weissig V, Whiteman KR and Torchilin VP (1998) Accumulation of protein-loaded long-circulating micelles and liposomes in subcutaneous Lewis lung carcinoma in mice. Pharm Res 15:1552-1556.
181. Katayose S and Kataoka K (1997) Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer. Bioconj Chem 8:702-707.
182. Wolfert MA, Schacht EH, Toncheva V, Ulbrich K, Nazarova O and Seymour LW (1996) Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymers. Hum Gene Ther 7:2123-2133.
183. Vinogradov SV, Bronich TK and Kabanov AV (1998) Self-assembly of polyamine-poly(ethylene glycol) copolymers with phosphorothioate oligonucleotides. Bioconjug Chem 9:805-812.
184. Itaka K, Harada A, Nakamura K, Kawaguchi H and Kataoka K (2002) Evaluation by fluorescence resonance energy transfer of the stability of nonviral gene delivery vectors under physiological conditions. Biomacromolecules 3:841-845.
185. Roy S, Zhang K, Roth T, Vinogradov S, Kao RS and Kabanov A (1999) Reduction of fibronectin expression by intravitreal administration of antisense oligonucleotides. Nat Biotechnol 17:476-479.
186. Ogris M, Steinlein P, Kursa M, Mechtler K, Kircheis R and Wagner E (1998) The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther 5:1425-1433.
187. Oupicky D, Ogris M, Howard KA, Dash PR, Ulbrich K and Seymour LW (2002) Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation. Mol Ther 5:463-472.
188. Harada-Shiba M, Yamauchi K, Harada A, Takamisawa I, Shimokado K and Kataoka K (2002) Polyion complex micelles as vectors in gene therapy-pharmacokinetics and in vivo gene transfer. Gene Ther 9:407-414.
189. Choi YH, Liu F, Park JS and Kim SW (1998) Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-tapgeted gene carrier. Bioconjug Chem 9:708-718.
190. Vinogradov S, Batrakova E, Li S and Kabanov A (1999) Polyion complex micelles with protein-modified corona for receptor-mediated delivery of oligonucleotides into cells. Bioconjug Chem 10:851-860.
191. Ward CM, Pechar M, Oupicky D, Ulbrich K and Seymour LW (2002) Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate-mediated targeting in vitro and prolonged plasma circulation in vivo. J Gene Med 4:536-547.
192. Nguyen HK, Lemieux P, Vinogradov SV, Gebhart CL, Guerin N, Paradis G, Bronich TK, Alakhov VY and Kabanov AV (2000) Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents. Gene Ther 7:126-138.
193. Gebhart CL, Sriadibhatla S, Vinogradov S, Lemieux P, Alakhov V and Kabanov AV (2002) Design and formulation of polyplexes based on pluronic-polyethyleneimine conjugates for gene transfer. Bioconjug Chem 13:937-944.
194. Belenkov AI, Alakhov VY, Kabanov AV, Vinogradov SV, Panasci LC, Monia BP and Chow TY (2004) Polyethyleneimine grafted with pluronic P85 enhances Ku86 antisense delivery and the ionizing radiation treatment efficacy in vivo. Gene Ther 11:1665-1672.
195. Yokoyama M, Miyauchi M, Yamada N, Okano T, Sakurai Y, Kataoka K and Inoue S (1990) Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res 50:1693-1700.
196. Nakanishi T, Fukushima S, Okamoto K, Suzuki M, Matsumura Y, Yokoyama M, Okano T, Sakurai Y and Kataoka K (2001) Development of the polymer micelle carrier system for doxorubicin. J Control Rel 74:295-302.
197. Danson S, Ferry D, Alakhov V, Margison J, Kerr D, Jowle D, Brampton M, Halbert G and Ranson M (2004) Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer. Br J Cancer 90:2085-2091.
198. Valle JW, Lawrance J, Brewer J, Clayton A, Corrie P, Alakhov V and Ranson M (2004) A phase II, window study of SP1049C as first-line therapy in inoperable metastatic adenocarcinoma of the oesophagus. 2004 ASCO Annual Meeting Vol. Abstract No: 4195.
199. Kim TY, Kim DW, Chung JY, Shin SG, Kim SC, Heo DS, Kim NK and Bang YJ (2004) Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clin Cancer Res 10:3708-3716.